SINGAPORE, 29 May 2025 - China Life Insurance (Singapore) Pte. Ltd. (“China Life Singapore”) and Singapore Institute of Advanced Medicine Holdings Ltd (“SAM Holdings”) signed a Memorandum of Understanding (MOU) to establish a long-term and comprehensive strategic partnership. Under the agreement, both parties will collaborate across areas including client referrals, preferential services, knowledge exchange, and professional consultancy. The partnership aims to jointly develop a competitive and influential “Insurance + Healthcare” service ecosystem in Singapore and drive sustainable, win-win growth for both organisations.

As one of Singapore’s leading private healthcare groups, SAM Holdings specialises in precision medicine, providing services including proton therapy, radiopharmaceutical oncology, comprehensive health screening, and chronic disease management. Adhering to a “patient-centric” philosophy, the group continuously promotes medical innovation and service enhancement, delivering systematic, personalised care powered by advanced technology and compassionate service.

China Life Singapore is dedicated to empowering clients with comprehensive financial solutions under its 'Insurance+' strategy. As an insurance company, we provide essential protection-based insurance alongside innovative wealth accumulation products, safeguarding clients' health and wealth for their long-term financial security and prosperity. By integrating with sectors such as healthcare, education, retirement, taxation, investment, legal services, and lifestyle, the company is building a vertical ecosystem that extends insurance services beyond traditional boundaries. Through this approach, it delivers high-quality “product + service” solutions and provides star-rated, full-lifecycle support to customers across an expanded value chain.

At the signing ceremony, Mr. Zeng Baqun, Deputy General Manager of China Life Singapore, and Mr. Paul Yeo, Chief Operating Officer of SAM Holdings, signed the agreement on behalf of their respective organisations. The signing was witnessed by Mr. Lin Xiangyang, Chief Executive of China Life Singapore, and Dr. Djeng Shih Kien, Chief Executive Officer of SAM Holdings.

Mr. Lin Xiangyang, Chief Executive of China Life Singapore, remarked that the partnership signals a new chapter of strategic collaboration in the “Greater Health” domain. Looking ahead, the company will continue to embrace a customer-centric philosophy while exploring integrated healthcare and insurance solutions. By working closely on platform co-development, resource integration, and product innovation, the two parties aim to enhance and elevate the “insurance + healthcare” ecosystem. Through complementary strengths and a shared vision, they strive to build a forward-looking, efficient, and sustainable health protection model—ultimately delivering greater value to customers and making a meaningful impact in the local community.